Prevention and Treatment of Side Effects of Immunotherapy for Bladder Cancer

Author:

Lou Kecheng,Feng Shangzhi,Zhang Guoxi,Zou Junrong,Zou Xiaofeng

Abstract

Bladder cancer (BC) is one of the most important tumors of the genitourinary system, associated with high morbidity and mortality rates. Over the years, various antitumor treatments have been developed, and immunotherapy is one of the most effective methods. Immunotherapy aims to activate the body’s immune system to kill cancer cells. It has been established that immunotherapy drugs can be classified into “non-targeted” and “targeted” drugs depending on their site of action. Immunotherapy is reportedly effective for BC. Even though it can attack cancer cells, it can also cause the immune system to attack healthy cells, which can occur at any time during treatment and sometimes even after immunotherapy is stopped. Importantly, different types of immunotherapies can cause different side effects. Side effects may manifest themselves as signs or as symptoms. The prevention and treatment of side effects caused by immunotherapy is an important part of cancer patient management.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangxi Province

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference128 articles.

1. FerlayJ Global Cancer Observatory: Cancer Today2018

2. Nivolumab Versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer;Brahmer;N Engl J Med,2015

3. The Global Burden of Urinary Bladder Cancer: An Update;Richters;World J Urol,2020

4. Immune Checkpoint Inhibitors for Urothelial Carcinoma;Kim;Investig Clin Urol,2018

5. Epidemiology of Bladder Cancer;Saginala;Med Sci (Basel),2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3